{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T17:06:22Z","timestamp":1781888782268,"version":"3.54.5"},"update-to":[{"DOI":"10.1002\/14651858.cd007603","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,8,27]],"date-time":"2015-08-27T00:00:00Z","timestamp":1440633600000}}],"reference-count":61,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007603.pub2","type":"journal-article","created":{"date-parts":[[2015,8,27]],"date-time":"2015-08-27T15:12:15Z","timestamp":1440688335000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty"],"prefix":"10.1002","volume":"2015","author":[{"given":"Minawaer","family":"Abudou","sequence":"first","affiliation":[{"name":"Xinjiang Medical University; The Eye Department of the First Affiliated Hospital; Xinjiang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taixiang","family":"Wu","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Chinese Clinical Trial Registry, Chinese Ethics Committee of Registering Clinical Trials; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R","family":"Evans","sequence":"additional","affiliation":[{"name":"London School of Hygiene & Tropical Medicine; Cochrane Eyes and Vision Group, ICEH; Keppel Street London UK WC1E 7HT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyi","family":"Chen","sequence":"additional","affiliation":[{"name":"First Affiliated Hospital of Xinjiang Medical University; Eye Department; Xinjiang China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,8,27]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD007603.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1038\/eye.2008.402","article-title":"Mycophenolate mofetil (MMF) following penetrating high risk keratoplasty: long-term results of a prospective, randomised, multicentre study","volume":"23","author":"Birnbaum","year":"2009","journal-title":"Eye"},{"issue":"6","key":"10.1002\/14651858.CD007603.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1432-2277.2005.00126.x","article-title":"Systemic mycophenolate mofetil avoids immune reactions in penetrating high-risk keratoplasty: preliminary results of an ongoing prospectively randomized multicentre study","volume":"18","author":"Reinhard","year":"2005","journal-title":"Transplant International"},{"issue":"11","key":"10.1002\/14651858.CD007603.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1136\/bjo.2009.172577","article-title":"Efficacy of topical ciclosporin A for treatment and prevention of graft rejection in corneal grafts with previous rejection episodes","volume":"94","author":"Javadi","year":"2010","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD007603.pub2-BIB0004|cit4","unstructured":"NCT01028443 Efficacy of topical cyclosporine A for treatment and prevention of graft rejection in corneal grafts with previous rejection episodes clinicaltrials.gov\/ct2\/show\/record\/NCT01028443"},{"issue":"5","key":"10.1002\/14651858.CD007603.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s004170100285","article-title":"Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomised prospective clinical trial","volume":"239","author":"Reinhard","year":"2001","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD007603.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2008-1034699","article-title":"Mycophenolate mofetil after penetrating high risk keratoplasty. A pilot study","volume":"215","author":"Reinhard","year":"1999","journal-title":"Klinische Monatsblatter fur Augenheilkunde"},{"issue":"2","key":"10.1002\/14651858.CD007603.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1432-2277.2004.00006.x","article-title":"Topical FK506 as immunoprophylaxis after allogeneic penetrating normal-risk keratoplasty: a randomised clinical pilot study","volume":"18","author":"Reinhard","year":"2005","journal-title":"Transplant International"},{"issue":"8","key":"10.1002\/14651858.CD007603.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00417-010-1388-8","article-title":"Efficacy of topical cyclosporine A 2% in prevention of graft rejection in high-risk keratoplasty: a randomised controlled trial","volume":"248","author":"Sinha","year":"2010","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD007603.pub2-BIB0009|cit9","first-page":"407","article-title":"The randomized, double blindness, multi-center clinical trail for CsA on rejection following PRK","volume":"27","author":"Zhang","year":"2009","journal-title":"Chinese Ophthalmic Research"},{"issue":"5","key":"10.1002\/14651858.CD007603.pub2-BIB0010|cit10","first-page":"420","article-title":"Suppression of corneal allograft rejection by topical cyclosporine A in high-risk keratoplasty","volume":"21","author":"He","year":"1999","journal-title":"China Academic Journal Electronic Publishing House"},{"issue":"4","key":"10.1002\/14651858.CD007603.pub2-BIB0011|cit11","first-page":"360","article-title":"Prevention and treatment of topical FK506 for allograft rejection after therapeutic total keratoplasty","volume":"25","author":"Liu","year":"2007","journal-title":"Chinese Journal of Practice Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD007603.pub2-BIB0012|cit12","first-page":"1781","article-title":"Comparative research of local versus systematic use glucocorticoids for rejection after keratoplasty","volume":"13","author":"Lu","year":"2009","journal-title":"Chinese Laboratory Diagnosticology"},{"key":"10.1002\/14651858.CD007603.pub2-BIB0013|cit13","unstructured":"NCT00553735 The prophylactic use of topical cyclosporine A 0.05% (Restasis) to prevent onset and progression of graft-versus-host disease-related dry eye clinicaltrials.gov\/ct2\/show\/record\/NCT00553735"},{"issue":"6","key":"10.1002\/14651858.CD007603.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00003226-199911000-00003","article-title":"Penetrating keratoplasty in patients with atopic dermatitis with and without systemic cyclosporin A","volume":"18","author":"Reinhard","year":"1999","journal-title":"Cornea"},{"issue":"1","key":"10.1002\/14651858.CD007603.pub2-BIB0015|cit15","first-page":"64","article-title":"Administration of immunosuppressive drug and corticosteroid after penetrating keratoplasty in fungal corneal ulcer","volume":"19","author":"Wu","year":"2001","journal-title":"Chinese Ophthalmic Research"},{"issue":"6","key":"10.1002\/14651858.CD007603.pub2-BIB0017|cit16","first-page":"627","article-title":"Cyclosporin A combined with dexamethasone in preventing and treating immune rejection after penetrating keratoplasty","volume":"28","author":"Xi","year":"2003","journal-title":"Bulletin of Hunan Medical University"},{"issue":"6","key":"10.1002\/14651858.CD007603.pub2-BIB0016|cit17","first-page":"30","article-title":"Effects of topical cyclosporin A and cyclosporin A combined dethmathason for long term on immune rejection of high risk corneal transplantation","volume":"14","author":"Xi","year":"2004","journal-title":"Chinese Journal of Modern Medicine"},{"issue":"6","key":"10.1002\/14651858.CD007603.pub2-BIB0018|cit18","first-page":"43","article-title":"Suppression of corneal allograft rejection by topical FK506 and cyclosporine A in penetrating keratoplasty","volume":"14","author":"Ye","year":"2004","journal-title":"Journal of Guangdong Pharmaceutical College"},{"issue":"3","key":"10.1002\/14651858.CD007603.pub2-BIB0019|cit19","first-page":"147","article-title":"Suppression of corneal allograft rejection by systemic cyclosporine A in high-risk keratoplasty","volume":"14","author":"Zhao","year":"2005","journal-title":"Chinese Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD007603.pub2-BIB0020|cit20","first-page":"115","article-title":"The effects of topical corticosteroid treatment on the chronic corneal allograft dysfunction after penetrating keratoplasty","volume":"29","author":"Zhou","year":"2008","journal-title":"Journal of Tongji University (Medical Science)"},{"key":"10.1002\/14651858.CD007603.pub2-BIB0021|cit21","unstructured":"NCT00409656 Prospective, randomized trial of basiliximab (Simulect) in the prophylaxis of high-risk keratoplasty patients clinicaltrials.gov\/ct2\/show\/record\/NCT00409656"},{"issue":"6","key":"10.1002\/14651858.CD007603.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00003226-200208000-00018","article-title":"Danger of systemic cyclosporine for corneal graft","volume":"21","author":"Algros","year":"2002","journal-title":"Cornea"},{"issue":"3","key":"10.1002\/14651858.CD007603.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00003226-199007000-00002","article-title":"Update on topical cyclosporin A. Background, immunology, and pharmacology","volume":"9","author":"Belin","year":"1990","journal-title":"Cornea"},{"issue":"2","key":"10.1002\/14651858.CD007603.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.ICL.0000062460.03555.32","article-title":"Topical cyclosporine in pediatric keratoplasty","volume":"29","author":"Cosar","year":"2003","journal-title":"Eye and Contact Lens"},{"key":"10.1002\/14651858.CD007603.pub2-BIB0025|cit25","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"6","key":"10.1002\/14651858.CD007603.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/00003226-200011000-00010","article-title":"Trends in the indications for penetrating keratoplasty in the midwestern United States","volume":"19","author":"Dobbins","year":"2000","journal-title":"Cornea"},{"issue":"2","key":"10.1002\/14651858.CD007603.pub2-BIB0027|cit27","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"issue":"10","key":"10.1002\/14651858.CD007603.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1432-2277.2007.00528.x","article-title":"Calcineurin inhibitor-free immunosuppression in kidney transplantation","volume":"20","author":"Guerra","year":"2007","journal-title":"Transplant International"},{"key":"10.1002\/14651858.CD007603.pub2-BIB0029|cit29","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD007603.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0002-9394(89)90494-7","article-title":"The use of cyclosporine in high-risk keratoplasty","volume":"107","author":"Hill","year":"1989","journal-title":"American Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD007603.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0161-6420(91)32291-7","article-title":"Corticosteroids in corneal graft rejection. Oral versus single pulse therapy","volume":"98","author":"Hill","year":"1991","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD007603.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0161-6420(13)31253-6","article-title":"Systemic cyclosporine in high-risk keratoplasty. Short versus long-term therapy","volume":"101","author":"Hill","year":"1994","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD007603.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0161-6420(98)91030-2","article-title":"Ten-year postoperative results of penetrating keratoplasty","volume":"105","author":"Ing","year":"1998","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD007603.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0021-5155(99)00223-3","article-title":"Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty","volume":"44","author":"Inoue","year":"2000","journal-title":"Japanese Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD007603.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/ajmg.a.32715","article-title":"Intrauterine exposure to mycophenolate mofetil and multiple congenital anomalies in a newborn: possible teratogenic effect","volume":"149(A)","author":"Jackson","year":"2009","journal-title":"American Journal of Medical Genetics Part A"},{"issue":"8","key":"10.1002\/14651858.CD007603.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S1701-2163(16)34622-9","article-title":"Prenatal exposure to mycophenolate mofetil: an updated estimate","volume":"32","author":"Klieger-Grossmann","year":"2010","journal-title":"Journal of Obstetrics and Gynaecology of Canadian"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD007603.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1097\/01.tp.0000186386.13597.cb","article-title":"Toxicity-sparing protocols using mycophenolate mofetil in renal transplantation","volume":"80","author":"Land","year":"2005","journal-title":"Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD007603.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00003226-199707000-00007","article-title":"Indications for penetrating keratoplasty in Canada, 1986-1995","volume":"16","author":"Liu","year":"1997","journal-title":"Cornea"},{"issue":"9","key":"10.1002\/14651858.CD007603.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0161-6420(94)31138-9","article-title":"Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group","volume":"101","author":"Maguire","year":"1994","journal-title":"Ophthalomology"},{"issue":"2","key":"10.1002\/14651858.CD007603.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1087-0024.2003.00803.x","article-title":"Mechanisms of immune privilege in the eye and hair follicle","volume":"8","author":"Niederkorn","year":"2003","journal-title":"Journal of Investigative Dermatology. Symposium Proceedings"},{"key":"10.1002\/14651858.CD007603.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2013.06.011","article-title":"The eye: A window to the soul of the immune system","volume":"45","author":"Perez","year":"2013","journal-title":"Journal of Autoimmunity"},{"issue":"4","key":"10.1002\/14651858.CD007603.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.18773\/austprescr.2006.064","article-title":"Immunosuppressants - mechanisms of action and monitoring","volume":"29","author":"Pillans","year":"2006","journal-title":"Australian Prescriber"},{"issue":"10","key":"10.1002\/14651858.CD007603.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.ophtha.2006.05.022","article-title":"Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes","volume":"113","author":"Price","year":"2006","journal-title":"Ophthalmology"},{"issue":"Pt 3","key":"10.1002\/14651858.CD007603.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/eye.1997.75","article-title":"Changing indications for penetrating keratoplasty in the west of Scotland from 1970 to 1995","volume":"11","author":"Ramsay","year":"1997","journal-title":"Eye"},{"issue":"3","key":"10.1002\/14651858.CD007603.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.ico.0000178731.42187.46","article-title":"Prevention and treatment of corneal graft rejection: current practice patterns (2004)","volume":"25","author":"Randleman","year":"2006","journal-title":"Cornea"},{"issue":"8","key":"10.1002\/14651858.CD007603.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1016\/S0041-1345(98)01434-1","article-title":"Mycophenolate mofetil and FK506: two novel immunosuppressants in murine corneal transplantation","volume":"30","author":"Reis","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"10","key":"10.1002\/14651858.CD007603.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s004170050159","article-title":"Comparative investigation of FK506 and cyclosporin A in murine corneal transplantation","volume":"236","author":"Reis","year":"1998","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD007603.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1136\/bjo.83.11.1268","article-title":"Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial","volume":"83","author":"Reis","year":"1999","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD007603.pub2-BIB0049|cit49","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"3","key":"10.1002\/14651858.CD007603.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/bjo.64.3.148","article-title":"Effect of cyclosporin A on the survival of corneal grafts in rabbits","volume":"64","author":"Shepherd","year":"1980","journal-title":"British Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD007603.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00044067-199608000-00007","article-title":"Mycophenolate mofetil (CellCept): immunosuppression on the cutting edge","volume":"7","author":"Siconolfi","year":"1996","journal-title":"AACN Clinical Issues"},{"issue":"10","key":"10.1002\/14651858.CD007603.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0161-6420(01)00759-X","article-title":"Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts","volume":"108","author":"Sloper","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD007603.pub2-BIB0053|cit53","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD007603.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10792-007-9100-7","article-title":"Pharmacologic strategies in the prevention and treatment of corneal transplant rejection","volume":"28","author":"Tabbara","year":"2007","journal-title":"International Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD007603.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2005.03.012","article-title":"Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy","volume":"56","author":"Taylor","year":"2005","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"7","key":"10.1002\/14651858.CD007603.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0161-6420(03)00463-9","article-title":"Long-term graft survival after penetrating keratoplasty","volume":"110","author":"Thompson","year":"2003","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD007603.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/ije\/dyh300","article-title":"Investigating patient exclusion bias in meta-analysis","volume":"34","author":"Tierney","year":"2005","journal-title":"International Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD007603.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/09273948.2010.498657","article-title":"Clinical review: topical ophthalmic use of cyclosporin A","volume":"18","author":"Utine","year":"2010","journal-title":"Ocular Immunology and Inflammation"},{"issue":"6","key":"10.1002\/14651858.CD007603.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/01.tp.0000185197.37824.35","article-title":"How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis","volume":"81","author":"Williams","year":"2006","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD007603.pub2-BIB0060|cit60","first-page":"632","article-title":"Early ocular chemokine gene expression and leukocyte infiltration after high-risk corneal transplantation","volume":"11","author":"Yamagami","year":"2005","journal-title":"Molecular Vision"},{"issue":"1","key":"10.1002\/14651858.CD007603.pub2-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007603","article-title":"Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty","author":"Wei","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007603.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T08:02:50Z","timestamp":1726732970000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007603.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,27]]},"references-count":61,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007603.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,27]]}}}